Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase II trial of EVT 101 in patients with neuropathic pain.

Trial Profile

Phase II trial of EVT 101 in patients with neuropathic pain.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 28 Mar 2011

At a glance

  • Drugs EVT 101 (Primary)
  • Indications Neuropathic pain
  • Focus Therapeutic Use
  • Sponsors Evotec AG
  • Most Recent Events

    • 20 Nov 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top